Abraxas BioScience (ABXL) is a biopharmaceutical innovator committed to addressing severe medical conditions with significant unmet needs through its robust pipeline of proprietary drug candidates. The company utilizes cutting-edge technologies in drug discovery to develop transformative therapies aimed at improving patient outcomes. With a strong focus on scientific integrity and regulatory adherence, ABXL collaborates with leading academic institutions and industry partners to enhance its research capabilities and accelerate the delivery of effective healthcare solutions.